Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?

Buck SA, Madhavan SS, Sanders LH.

Mol Neurodegener Adv · 2026-09-14

DOI: 10.1186/s44477-026-00047-8PMID: 42745993

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cu/Cu<sub>2</sub>O-embedded carbon from Cu-MOF integrated with MWCNTs-COOH for sensitive levodopa detection in biological samples.

Ma N, Wei A, Peng H, Xie L, Jin Y, Li G.

Colloids Surf B Biointerfaces · 2026-09-12

DOI: 10.1016/j.colsurfb.2026.116177PMID: 42743869

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Langeskov-Christensen M, Borghammer P, Østergaard SD, Rohde C.

Parkinsonism Relat Disord · 2026-09-12

DOI: 10.1016/j.parkreldis.2026.108984PMID: 42766893

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report).

Hou L, Ma X, Wang C, Ji L, Peng P.

Front Psychiatry · 2026-09-11

DOI: 10.3389/fpsyt.2026.1935514PMID: 42798501

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease.

Wakamatsu N, Norimura S, Nakagawa M, Hirao A, Mukai M, Urai Y, Toda T, Tsuji S, Mitsui J.

Neurol Sci · 2026-09-11

DOI: 10.1007/s10072-026-09361-1PMID: 42726292

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Vogt HK, Pojani C, Devonport J, McGown A, Firth G, Doykov I, Nikolaenko V, Anagianni S, Valdivia LE, Khalil Y, Bodnár N, Kállay C, Dadswell C, Gonzalez-Mendez R, Purchase R, Platt FM, Zacconi FCM, Geard AF, Heywood WE, Mills K, Mills PB, Rahim AA, Rihel J, Wilson SW, Kostakis GE, Spencer J, Tuschl K.

Biochem Pharmacol · 2026-09-11

DOI: 10.1016/j.bcp.2026.118465PMID: 42727654

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy.

Bhise MR, Thejomoorthy K, Kumar M, Patel PKN, Mahajan V, Naquvi KJ, Ansari I, Kumar A.

Curr Drug Deliv · 2026-09-11

DOI: 10.2174/0115672018474663260907142216PMID: 42764574

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.

Jiang DY, Yao SY, Du MQ, Lin LX, Kang XH, Peng Y.

Exp Neurol · 2026-09-11

DOI: 10.1016/j.expneurol.2026.116022PMID: 42727800

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Retromer-targeted therapy for neurodegenerative diseases.

Persico M, Tuithung S, Lorenzo A, Crawford D, Eleuteri S, Simon DK.

Mol Neurodegener · 2026-09-10

DOI: 10.1186/s13024-026-00971-zPMID: 42723096

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Repetitive transcranial magnetic stimulation as adjunctive treatment in Parkinson's disease: are we missing opportunities? An umbrella and scoping review.

Mendonça MD, Cotovio G, Barbosa R, Lefaucheur JP, Ferreira JJ, Oliveira-Maia AJ.

Brain Commun · 2026-09-09

DOI: 10.1093/braincomms/fcag346PMID: 42813094

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Trauma Releasing Exercises as a Treatment Technique: A Scoping Review.

Roos LAJ, van Niekerk K, Tönsing KM.

Occup Ther Health Care · 2026-09-09

DOI: 10.1080/07380577.2026.2726931PMID: 42713778

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Therapeutics candidates and repurposing strategies to target parkinson's disease pathology: current evidence and future directions.

Dhanush Y, Nizamuddin ND, Neelima S, Kalpana S, Arla KK, Ganesh VS, Sree PC, Rohitha C.

Metab Brain Dis · 2026-09-09

DOI: 10.1007/s11011-026-01961-2PMID: 42714656

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

20.491 makale bulundu

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?

Cu/Cu<sub>2</sub>O-embedded carbon from Cu-MOF integrated with MWCNTs-COOH for sensitive levodopa detection in biological samples.

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report).

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease.

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy.

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.

Retromer-targeted therapy for neurodegenerative diseases.

Repetitive transcranial magnetic stimulation as adjunctive treatment in Parkinson's disease: are we missing opportunities? An umbrella and scoping review.

Trauma Releasing Exercises as a Treatment Technique: A Scoping Review.

Therapeutics candidates and repurposing strategies to target parkinson's disease pathology: current evidence and future directions.

Filtreler